FierceBiotech

In one quick email a day, FierceBiotech keeps you up-to-speed on Full spectrum clinical stage drug development, deals and data on the most compelling therapies in the pipeline, the ongoing restructuring of the industry’s R&D efforts, with a sharp focus on leadership.

Request Free!

FierceBiotech

In one quick email a day, FierceBiotech keeps you up-to-speed on Full spectrum clinical stage drug development, deals and data on the most compelling therapies in the pipeline, the ongoing restructuring of the industry’s R&D efforts, with a sharp focus on leadership.

Request Free!

Bioscience Technology

Each issue of Bioscience Technology covers new technologies and applications in life science research. It’s sent to scientists doing biology-based research in pharmaceutical, academic, biotech, government and commercial labs. Bioscience Technology is p…

Trump in 30 – Healthcare & Medical Content Roundup

Our team of distinguished journalists have highlighted a diverse collection of reporting on Trump’s activity in health and medicine. Below are their picks:

  • How Trump was named ‘Grand Benefactor’ for a Dana-Farber gala without donating a penny
  • In Trump’s America, towns in poor health don’t think he will save them
  • What does Donald Trump’s win mean for science and medicine?
  • Changes coming for Medicaid after Trump’s election. Will patients lose coverage?
  • An abortion doctor on Trump’s win: ‘I fear for my life. I fear for my patients’
  • He’s a Trump in-law who has bet big on Obamacare. What now?
  • Who’s the billionaire doctor palling around with Donald Trump?
  • Could the FDA be dismantled under Trump?
  • Trump promised to bring back coal. Now some worry he will take away miners’ black lung benefits
  • Meeting with Trump emboldens anti-vaccine activists, who see an ally in the Oval Office

Along with this free content sampler, you’ll also receive a complimentary subscription to ‘Morning Rounds’, STAT’s email newsletter that delivers a daily dose of news in health and medicine.

BONUS OFFER: An exclusive offer for STAT Plus, is awaiting inside the document. STAT Plus, a premium subscription that provides you with access to exclusive, in-depth pharma, biotech, business, and policy coverage, keeping you on top of what’s happening in the industry – as it happens. As a token of our appreciation, we would like to give you a 33% discount off the first year of your STAT Plus subscription – and your first 30 days free!

Simply request the above sampler to receive access to the promo code.

About us: STAT delivers fast, deep, and tough-minded journalism. We take you inside science labs and hospitals, biotech boardrooms, and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stores that matter to us all.

Request Free!

Morning Rounds – Healthcare & Medical Content Roundup

Our team of distinguished journalists have highlighted a diverse collection of original editorial in health and medicine. Below are their picks:

  • Dope Sick: A harrowing story of best friends, addiction – and a stealth killer
  • One man’s desperate quest for a brutal surgery
  • For cancer patients, newest treatments force the ultimate decision, with no room for error
  • In the dark of night, a hunt for a deadly bug in the name of science
  • Episode 1: Man inside the hard drive ‘Silicon Valley arrogance’? Google misfires as it strives to turn Star Trek fiction into reality
  • Disqualified after concussions, college football players recruited back onto the field
  • Is Adam Feuerstein the most feared man in biotech?
  • 26 overdoses in just hours: Inside a community on the front lines of the opioid epidemic
  • At a hospice facility for children, a long goodbye is made a little less lonely

Along with this free content sampler, you’ll also receive a complimentary subscription to ‘Morning Rounds’, STAT’s email newsletter that delivers a daily dose of news in health and medicine.

BONUS OFFER: An exclusive offer for STAT Plus, is awaiting inside the document. STAT Plus, a premium subscription that provides you with access to exclusive, in-depth pharma, biotech, business, and policy coverage, keeping you on top of what’s happening in the industry – as it happens. As a token of our appreciation, we would like to give you a 33% discount off the first year of your STAT Plus subscription – and your first 30 days free!

Simply request the above sampler to receive access to the promo code.

About us: STAT delivers fast, deep, and tough-minded journalism. We take you inside science labs and hospitals, biotech boardrooms, and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stores that matter to us all.

Request Free!

STAT – Special Report – Healthcare & Medical Content Roundup

Our team of distinguished journalists have highlighted a diverse collection of original health and medicine editorial targeting the opioid crisis. Below are their picks:

  • 26 overdoses in just hours: Inside a community on the front lines of the opioid epidemic
  • Dope Sick: A harrowing story of best friends, addiction – and a stealth killer
  • Illegal street drugs, not prescriptions, now powering opioid abuse, study finds
  • Ohio police release photo of a 4-year-old in back of car with adults overdosed in front seats
  • ‘The story had to be told’: Ohio police official defends releasing photo of overdosed adults with boy
  • Public shaming of overdosed adults by police departments Facebook post is ‘morally repugnant’
  • Secret trove reveals bold ‘crusade’ to make OcyContin a blockbuster
  • A potent painkiller, and the drug maker’s marketing, are faulted in a woman’s death
  • After patient death, N.J. attorney general seeks to suspend doctor who prescribed fentanyl
  • Drug maker thwarted plan to limit OxyContin prescriptions at dawn of opioid epidemic

Along with this free content sampler, you’ll also receive a complimentary subscription to ‘Morning Rounds’, STAT’s email newsletter that delivers a daily dose of news in health and medicine.

BONUS OFFER: An exclusive offer for STAT Plus, is awaiting inside the document. STAT Plus, a premium subscription that provides you with access to exclusive, in-depth pharma, biotech, business, and policy coverage, keeping you on top of what’s happening in the industry – as it happens. As a token of our appreciation, we would like to give you a 33% discount off the first year of your STAT Plus subscription – and your first 30 days free!

Simply request the above sampler to receive access to the promo code.

About us: STAT delivers fast, deep, and tough-minded journalism. We take you inside science labs and hospitals, biotech boardrooms, and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stores that matter to us all.

Request Free!

The Readout – Healthcare & Medical Content Roundup

Our team of distinguished journalists have highlighted a diverse collection of biotech original editorial. Below are their picks:

  • Ego, ambition, and turmoil: Inside one of biotech’s most secretive startups
  • The EpiPen was her ‘baby.’ Now this pharma CEO is in the hot seat over price hikes
  • Juno halts its immunotherapy trial for cancer after three patient deaths
  • What does Donald Trump’s win mean for science and medicine?
  • Is Adam Feuerstein the most feared man in biotech?
  • Is Theranos finished? Watch for these 5 telltale signs
  • Meet one of the world’s most groundbreaking scientists. He’s 34.
  • A radically simple idea may open the door to a new world of antibiotics
  • Tasty and easy to take, a new ADHD drug alarms some psychiatrics
  • There’s new hope for treating hair loss – for women, too

Along with this free content sampler, you’ll also receive a complimentary subscription to ‘Morning Rounds’, STAT’s email newsletter that delivers a daily dose of news in health and medicine.

BONUS OFFER: An exclusive offer for STAT Plus, is awaiting inside the document. STAT Plus, a premium subscription that provides you with access to exclusive, in-depth pharma, biotech, business, and policy coverage, keeping you on top of what’s happening in the industry – as it happens. As a token of our appreciation, we would like to give you a 33% discount off the first year of your STAT Plus subscription – and your first 30 days free!

Simply request the above sampler to receive access to the promo code.

About us: STAT delivers fast, deep, and tough-minded journalism. We take you inside science labs and hospitals, biotech boardrooms, and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stores that matter to us all.

Request Free!

On Call – Healthcare & Medical Content Roundup

Our team of distinguished journalists have highlighted a diverse collection of original editorial in healthcare. Below are their picks:

  • Hospitals are throwing out organs and denying transplants to meet federal standards
  • She’s calling for a healthcare revolution. The radical first step: listen to patients
  • 5 reasons to take hospital ratings with a big grain of salt
  • Get a new body part and go home the same day: the rise of the ‘bedless hospital’
  • Looming question for medical students: Will they be shut out of advanced training?
  • Sugar industry secretly paid for favorable Harvard research
  • Cigarettes in hospitals. 5 practices that may soon look just as outdated
  • Hospitals face budget woes with switch to electronic records
  • Harvard has one of the best medical schools. Why does it ignore family practice?
  • The pay is low, the typing nonstop, but the medical scribe business is booming

Along with this free content sampler, you’ll also receive a complimentary subscription to ‘Morning Rounds’, STAT’s email newsletter that delivers a daily dose of news in health and medicine.

BONUS OFFER: An exclusive offer for STAT Plus, is awaiting inside the document. STAT Plus, a premium subscription that provides you with access to exclusive, in-depth pharma, biotech, business, and policy coverage, keeping you on top of what’s happening in the industry – as it happens. As a token of our appreciation, we would like to give you a 33% discount off the first year of your STAT Plus subscription – and your first 30 days free!

Simply request the above sampler to receive access to the promo code.

About us: STAT delivers fast, deep, and tough-minded journalism. We take you inside science labs and hospitals, biotech boardrooms, and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stores that matter to us all.

Request Free!